IL2 and neoplasm: When the tumor volume reached approximately 70 mm3, NK cells, R-NK cells or G-NK cells (5 × 106 cells per mouse) were administered to tumor-bearing mice and supplemented with IL-2 (1000 units) on Days 0, 3 and 6 (Fig. 4A).